Growth through strengthening existing businesses, R&D and M&A
First written in FY2016. 24 of 26 entries say "Restated". Latest entry: 2026-08-06.
19 other companies' latest entry also says "Advanced".
- 2026-08-06AdvancedEarnings presentation
「The Future Innovation Division was established in April 2025 as a business R&D organization that develops technologies into business value.」
Efforts to link research and development to business growth have taken concrete form, with the Future Innovation Division operating as a business R&D organization connecting research, business and the field. - FY2025-H1RestatedAnnual report
「R&D spending across the group during the six-month period ended 30 September was ¥11,428 million. There were also no material changes in the status of the group’s R&D activities during the six-month period ended 30 September.」
The group continues its R&D activities and disclosed R&D expenses of ¥11,428 million for the first half of 2025. It also states that there were no material changes in the status of R&D activities. - FY2023RestatedAnnual report
「R&D expenses for the fiscal year were ¥27,301 million, and the principal R&D activities and their results are as follows.」
The increase in R&D expenses and results in each business are disclosed, while the basic policy of group-wide R&D remains unchanged. - FY2023RestatedAnnual report
「To this end, we conduct group-wide R&D activities, combining our wide-ranging technologies in wireless and communications, microdevices, brakes and chemicals to create innovation and provide new value that contributes to a sustainable society. R&D expenses for the fiscal year were ¥27,301 million,」
The group continues its group-wide R&D and integration of its proprietary technologies, and disclosed R&D expenses of ¥27,301 million. - FY2023-Q3RestatedAnnual report
「R&D spending across the group during the nine-month period ended 30 September was ¥19,965 million. There were also no material changes in the status of the group’s R&D activities during the nine-month period ended 30 September.」
The group continues its R&D activities and disclosed R&D expenses of ¥19,965 million for the nine-month period ended 30 September. It also states that there were no material changes in the status of R&D activities. - FY2023-Q2RestatedAnnual report
「R&D spending across the group during the six-month period ended 30 June was ¥13,220 million. There were also no material changes in the status of the group’s R&D activities during the six-month period ended 30 June.」
The group continues its R&D activities and disclosed R&D expenses of ¥13,220 million for the six-month period ended 30 June. It also states that there were no material changes in the status of R&D activities. - FY2023-Q1RestatedAnnual report
「R&D spending across the group during the three-month period ended 31 March was ¥6,387 million. There were also no material changes in the status of the group’s R&D activities during the three-month period ended 31 March.」
The group continues its R&D activities and disclosed R&D expenses of ¥6,387 million. It also states that there were no material changes in the status of R&D activities. - FY2022-Q3RestatedAnnual report
「R&D spending across the group during the nine-month period ended 30 September was ¥18,266 million. There were also no material changes in the status of the group’s R&D activities during the nine-month period ended 30 September.」
The group continues its group-wide R&D activities and disclosed R&D expenses of ¥18,266 million for January through September 2022. It also states that there were no material changes in the status of R&D activities. - FY2022-Q2RestatedAnnual report
「R&D spending across the group during the six-month period ended 30 September was ¥11,631 million. There were also no material changes in the status of the group’s R&D activities during the six-month period ended 30 September.」
The group continues its group-wide R&D activities and disclosed R&D expenses of ¥11,631 million for the six-month period ended 30 September. It also states that there were no material changes in the status of R&D activities. - FY2021-Q3RestatedAnnual report
「R&D spending across the group during the nine-month period ended 30 September was ¥15,649 million. There were also no material changes in the status of the group’s R&D activities during the nine-month period ended 30 September.」
The group continues its group-wide R&D activities and disclosed R&D expenses of ¥15,649 million for January through September 2021. - FY2021-Q2RestatedAnnual report
「R&D spending across the group during the six-month period ended 30 September was ¥11,126 million. There were also no material changes in the status of the group’s R&D activities during the six-month period ended 30 September.」
The group continues its group-wide R&D policy and reports R&D expenses of ¥11,126 million for the six-month period ended 30 September. - FY2021-Q1RestatedAnnual report
「R&D spending across the group during the three-month period ended 30 June was ¥5,383 million. There were also no material changes in the status of the group’s R&D activities during the three-month period ended 30 June.」
The disclosure states that there were no material changes in R&D activities and reports R&D expenses of ¥5,383 million for the three-month period ended 30 June 2021. - FY2020RestatedAnnual report
「To this end, we conduct group-wide R&D activities, combining our wide-ranging technologies in wireless and communications, microdevices, brakes and chemicals to create innovation and provide new value that contributes to a sustainable society.」
The group continues its group-wide R&D and technology integration, with R&D expenses of ¥23,377 million for the fiscal year. - FY2020-Q2RestatedAnnual report
「R&D spending across the group during the six-month period ended 30 September was ¥11,419 million. There were also no material changes in the status of the group’s R&D activities during the six-month period ended 30 September.」
The disclosure states that there were no material changes in R&D activities and reports R&D expenses of ¥11,419 million for the first half of 2020. - FY2020-Q1RestatedAnnual report
「R&D spending across the group during the three-month period ended 30 June was ¥5,677 million. There were also no material changes in the status of the group’s R&D activities during the three-month period ended 30 June.」
The disclosure states that there were no material changes in R&D activities and reports R&D expenses of ¥5,677 million for the three-month period ended 30 June 2020. - FY2019RestatedAnnual report
「To this end, we conduct group-wide R&D activities, combining our wide-ranging technologies in wireless and communications, microdevices, brakes and chemicals to create innovation and provide new value that contributes to a sustainable society.」
The group continues its growth initiatives combining existing businesses, R&D and technology integration, with R&D expenses of ¥22,400 million for the fiscal year. - FY2019-Q3RestatedAnnual report
「R&D spending across the group during the nine-month period ended 31 December was ¥16,676 million. There were also no material changes in the status of the group’s R&D activities during the nine-month period ended 31 December.」
The disclosure states that there were no material changes in R&D activities and reports R&D expenses of ¥16,676 million for the nine-month period ended 31 December. - FY2019-Q2RestatedAnnual report
「R&D spending across the group during the six-month period ended 30 September was ¥10,967 million. There were also no material changes in the status of the group’s R&D activities during the six-month period ended 30 September.」
The disclosure states that there were no material changes in R&D activities and reports R&D expenses of ¥10,967 million for the six-month period ended 30 September. - FY2019-Q1RestatedAnnual report
「R&D spending across the group during the three-month period ended 30 June was ¥5,211 million. There were also no material changes in the status of the group’s R&D activities during the three-month period ended 30 June.」
The disclosure states that there were no material changes in R&D activities and reports R&D expenses of ¥5,211 million for the three-month period ended 30 June. - FY2018-Q3RestatedAnnual report
「R&D spending across the group during the six-month period ended 30 September was ¥14,190 million. There were also no material changes in the status of the group’s R&D activities during the six-month period ended 30 September.」
R&D expenses of ¥14,190 million were recorded, and the disclosure states that there were no material changes in R&D activities. - FY2018RestatedAnnual report
「R&D expenses for the fiscal year were ¥22,836 million, and the principal R&D activities and their results are as follows.」
The group continues its growth initiatives combining existing businesses, R&D and M&A, and recorded R&D expenses of ¥22,836 million. - FY2017-Q4RestatedAnnual report
「R&D spending across the group during the nine-month period ended 31 December was ¥16,000 million. The material changes in the status of R&D activities during the nine-month period ended 31 December are as follows.」
The disclosure states that there were no material changes in R&D activities and reports R&D spending of ¥16,000 million for the nine-month period ended 31 December. - FY2017-Q2RestatedAnnual report
「R&D spending across the group during the three-month period ended 30 June was ¥5,115 million. There were also no material changes in the status of the group’s R&D activities during the three-month period ended 30 June.」
The disclosure states that there were no material changes in R&D activities and reports R&D spending of ¥5,115 million for the three-month period ended 30 June. - FY2017RestatedAnnual report
「Driven by continuous innovation, we are advancing “strengthening existing businesses,” “realizing the results of R&D,” and “actively pursuing M&A.”」
The group continues its growth initiatives combining existing businesses, R&D and M&A. R&D spending is stated as ¥22,226 million. - FY2016-Q4RestatedAnnual report
「R&D spending across the group during the nine-month period ended 31 December was ¥16,353 million. There were also no material changes in the status of the group’s R&D activities during the nine-month period ended 31 December.」
The disclosure states that R&D activities continued and reports R&D spending of ¥16,353 million for the nine-month period ended 31 December. - FY2016First statedAnnual report
「As a Group, we are advancing “strengthening existing businesses,” “maximizing the results of R&D,” and “actively pursuing M&A.”」
Three Group-wide initiatives aimed at achieving the targets.